跳到主要导航 跳到搜索 跳到主要内容

Systemic treatment with telmisartan improves femur fracture healing in Mice

  • Xiong Zhao
  • , Jia Xing Wang
  • , Ya Fei Feng
  • , Zi Xiang Wu
  • , Yang Zhang
  • , Lei Shi
  • , Quan Chang Tan
  • , Ya Bo Yan
  • , Wei Lei
  • Xijing Hospital
  • PLA No. 309 Hospital

科研成果: 期刊稿件 › 文章 › 同行评审

18 引用 (Scopus)

摘要

Recent clinical studies indicated that angiotensin receptor blockers (ARBs) would decrease the risk of bone fractures in the elderly populations. There is little known about the role of the ARBs in the process of fracture healing. The purpose of the present study was to verify the hypothesis that systemic treatment with telmisartan has the ability to promote fracture healing. In this study, femur fractures were produced in 96 mature male BALB/c mice. Animals were treated with the ARBs telmisartan or vehicle. Fracture healing was analysed after 2, 5 and 10 weeks postoperatively using X-ray, biomechanical testing, histomorphometry, immunohistochemistry and micro-computed tomography (micro-CT). Radiological analysis showed the diameter of the callus in the telmisartan treated animals was significantly increased when compared with that of vehicle treated controls after two weeks of fracture healing. The radiologically observed promotion of callus formation was confirmed by histomorphometric analyses, which revealed a significantly increased amount of bone formation when compared with vehicle-treated controls. Biomechanical testing further showed a significantly greater peak torque at failure, and a higher torsional stiffness in telmisartan-treated animals compared with controls. There was an increased fraction of PCNA-positive cells and VEGF-positive cells in telmisartan-treated group compared with vehicle-treated controls. From the three-dimensional reconstruction of the bony callus, telmisartan-treated group significantly increased the values of BV/TV by 21.7% and CsAr by 26.0% compared to the vehicle-treated controls at 5 weeks post-fracture. In summary, we demonstrate in the current study that telmisartan could promote fracture healing in a mice model via increasing mechanical strength and improving microstructure. The most mechanism is probably by an increase of cell proliferation and neovascularization associated with a decreased VEGF expression in hypertrophic chondrocytes.

源语言英语
期刊论文编号e92085
期刊PLoS ONE
卷9
期3
DOI
出版状态已出版 - 18 3月 2014
已对外发布是

学术指纹

探究 'Systemic treatment with telmisartan improves femur fracture healing in Mice' 的科研主题。它们共同构成独一无二的学术指纹。

引用此